Clinical efficacy of tocilizumab treatment in severe and critical COVID-19 patients

doi:10.12998/wjcc.v8.i17.3763

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 8, Issue 17

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (5711)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-4) series, Tables (1-2) series.

Item

Count

PDF

360

WORD

166

HTML

2691

Figures (1-4)

321

Tables (1-2)

286

Sum=3824

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

774

Download

1113

Sum=1887

Sep 6, 2020 (publication date) through Jan 12, 2025

Times Cited of This Article

Times Cited (6)

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Clin Cases. Sep 6, 2020; 8(17): 3763-3773
Published online Sep 6, 2020. doi: 10.12998/wjcc.v8.i17.3763

Full Size Figure Download Figure

Figure 1 Improvement after tocilizumab treatment (computed tomography of the lung shows reduced lung inflammation).

Citation: Zeng J, Xie MH, Yang J, Chao SW, Xu EL. Clinical efficacy of tocilizumab treatment in severe and critical COVID-19 patients. World J Clin Cases 2020; 8(17): 3763-3773
URL: https://www.wjgnet.com/2307-8960/full/v8/i17/3763.htm
DOI: https://dx.doi.org/10.12998/wjcc.v8.i17.3763